Z-1317-2015 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-1317-2015 was initiated by Becton Dickinson & Company on Feb 19, 2015 and is designated Class II. Reason for recall: Becton Dickinson received an elevated number of complaints for blood or infusate/medication leakage due to tearing of the silicone septum. The recall status is terminated (terminated May 25, 2017). Affected quantity: 315,800 units.

Recall details

Product Type
Devices
Report Date
Apr 1, 2015
Initiation Date
Feb 19, 2015
Termination Date
May 25, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
315,800 units

Product description

BD Q-Syte Luer Access Split Septum, 0.16 ml, Sterile, Rx only, Catalog REF #385100, Manufacturer: Becton Dickinson Infusion Therapy Systems Inc. An accessory to an intravascular administration set that permits injection, gravity flow or withdrawal of fluids.

Reason for recall

Becton Dickinson received an elevated number of complaints for blood or infusate/medication leakage due to tearing of the silicone septum.

Distribution pattern

Distributed to the states of CA, CT, FL, IL, MA, ND, NY, OH and PA.

Code information

Lot #'s 4128925 and 4128926

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1317-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1317-2015. Report a data issue: hello@regdatalab.com.